32307524|t|ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
32307524|a|The spinocerebellar ataxia type 2 (SCA2) gene ATXN2 has a prominent role in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS). In addition to cerebellar ataxia, motor neuron disease is often seen in SCA2, and ATXN2 CAG repeat expansions in the long normal range increase ALS risk. Also, lowering ATXN2 expression in TDP-43 ALS mice prolongs their survival. Here we investigated the ATXN2 relationship with motor neuron dysfunction in vivo by comparing spinal cord (SC) transcriptomes reported from TDP-43 and SOD1 ALS mice and ALS patients with those from SCA2 mice. SC transcriptomes were determined using an SCA2 bacterial artificial chromosome mouse model expressing polyglutamine expanded ATXN2. SCA2 cerebellar transcriptomes were also determined, and we also investigated the modification of gene expression following treatment of SCA2 mice with an antisense oligonucleotide (ASO) lowering ATXN2 expression. Differentially expressed genes (DEGs) defined three interconnected pathways (innate immunity, fatty acid biosynthesis and cholesterol biosynthesis) in separate modules identified by weighted gene co-expression network analysis. Other key pathways included the complement system and lysosome/phagosome pathways. Of all DEGs in SC, 12.6% were also dysregulated in the cerebellum. Treatment of mice with an ATXN2 ASO also modified innate immunity, the complement system and lysosome/phagosome pathways. This study provides new insights into the underlying molecular basis of SCA2 SC phenotypes and demonstrates annotated pathways shared with TDP-43 and SOD1 ALS mice and ALS patients. It also emphasizes the importance of ATXN2 in motor neuron degeneration and confirms ATXN2 as a therapeutic target.
32307524	0	3	ALS	Disease	MESH:D000690
32307524	24	28	SCA2	Gene	20239
32307524	29	34	mouse	Species	10090
32307524	67	96	spinocerebellar ataxia type 2	Gene	20239
32307524	98	102	SCA2	Gene	20239
32307524	109	114	ATXN2	Gene	20239
32307524	173	202	amyotrophic lateral sclerosis	Disease	MESH:D000690
32307524	204	207	ALS	Disease	MESH:D000690
32307524	225	242	cerebellar ataxia	Disease	MESH:D002524
32307524	244	264	motor neuron disease	Disease	MESH:D016472
32307524	282	286	SCA2	Gene	20239
32307524	292	297	ATXN2	Gene	20239
32307524	354	357	ALS	Disease	MESH:D000690
32307524	379	384	ATXN2	Gene	20239
32307524	399	405	TDP-43	Gene	230908
32307524	406	409	ALS	Disease	MESH:D000690
32307524	410	414	mice	Species	10090
32307524	465	470	ATXN2	Gene	20239
32307524	489	513	motor neuron dysfunction	Disease	MESH:D016472
32307524	581	587	TDP-43	Gene	230908
32307524	592	596	SOD1	Gene	20655
32307524	597	600	ALS	Disease	MESH:D000690
32307524	601	605	mice	Species	10090
32307524	610	613	ALS	Disease	MESH:D000690
32307524	614	622	patients	Species	9606
32307524	639	643	SCA2	Gene	20239
32307524	644	648	mice	Species	10090
32307524	693	697	SCA2	Gene	20239
32307524	730	735	mouse	Species	10090
32307524	776	781	ATXN2	Gene	20239
32307524	783	787	SCA2	Gene	20239
32307524	920	924	SCA2	Gene	20239
32307524	925	929	mice	Species	10090
32307524	948	963	oligonucleotide	Chemical	MESH:D009841
32307524	979	984	ATXN2	Gene	20239
32307524	1091	1101	fatty acid	Chemical	MESH:D005227
32307524	1119	1130	cholesterol	Chemical	MESH:D002784
32307524	1388	1392	mice	Species	10090
32307524	1401	1406	ATXN2	Gene	20239
32307524	1569	1573	SCA2	Gene	20239
32307524	1636	1642	TDP-43	Gene	230908
32307524	1647	1651	SOD1	Gene	20655
32307524	1652	1655	ALS	Disease	MESH:D000690
32307524	1656	1660	mice	Species	10090
32307524	1665	1668	ALS	Disease	MESH:D000690
32307524	1669	1677	patients	Species	9606
32307524	1716	1721	ATXN2	Gene	20239
32307524	1725	1750	motor neuron degeneration	Disease	MESH:D009410
32307524	1764	1769	ATXN2	Gene	6311
32307524	Association	MESH:D000690	20655
32307524	Association	MESH:D002524	20239
32307524	Association	MESH:D000690	230908
32307524	Negative_Correlation	MESH:D009841	20239
32307524	Association	20239	230908
32307524	Association	MESH:D000690	20239
32307524	Association	MESH:D016472	20239

